argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands. Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL
INITIALIZE TERMINAL
Select up to 5 assets to monitor in your personal Watchlist. This builds your core market profile.
GUEST MODE: Watchlist is temporary. Login or Register to sync permanently and unlock Top 1-5 Champions.
UNITED STATES
